Zsuzsanna Veres
Hungarian Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zsuzsanna Veres.
Acta Veterinaria Hungarica | 2013
Gábor Mátis; Zsuzsanna Neogrády; György Csikó; Péter Gálfi; Hedvig Fébel; Katalin Jemnitz; Zsuzsanna Veres; Anna Kulcsár; Ákos Kenéz; Korinna Huber
The aim of the study was to investigate the in vivo epigenetic influences of dietary butyrate supplementation on the acetylation state of core histones and the activity of drug-metabolising microsomal cytochrome P450 (CYP) enzymes in the liver of broiler chickens in the starter period. One-day-old Ross 308 broilers were fed a starter diet without or with sodium butyrate (1.5 g/kg feed) for 21 days. After slaughtering, nucleus and microsome fractions were isolated from the exsanguinated liver by multi-step differential centrifugation. Histone acetylation level was detected from hepatocyte nuclei by Western blotting, while microsomal CYP activity was examined by specific enzyme assays. Hyperacetylation of hepatic histone H2A at lysine 5 was observed after butyrate supplementation, providing modifications in the epigenetic regulation of cell function. No significant changes could be found in the acetylation state of the other core histones at the acetylation sites examined. Furthermore, butyrate did not cause any changes in the drugmetabolising activity of hepatic microsomal CYP2H and CYP3A37 enzymes, which are mainly involved in the biotransformation of most xenobiotics in chicken. These data indicate that supplementation of the diet with butyrate probably does not have any pharmacokinetic interactions with simultaneously applied xenobiotics.
Journal of Colloid and Interface Science | 2017
Marcell Pálmai; Adrienn Pethő; Lívia Nagy; Szilvia Klébert; Zoltán May; Judith Mihály; András Wacha; Katalin Jemnitz; Zsuzsanna Veres; Ildiko Horvath; Krisztián Szigeti; Domokos Máthé; Zoltán Varga
The development of tissue specific magnetic resonance imaging (MRI) contrast agents (CAs) is very desirable to achieve high contrast ratio combined with excellent anatomical details. To this end, we introduce a highly effective manganese(II) containing silica material, with the aim to shorten the longitudinal (T1) relaxation time. The microporous silica nanospheres (MSNSs) with enlarged porosity and specific surface area were prepared by a surfactant assisted aqueous method. Subsequently, the surface silanol groups were amino-functionalized, reacted with diethylenetriaminepentaacetic (DTPA) dianhydride and finally deposited with Mn2+. After comprehensive characterization, the MRI properties of functionalized MSNSs were investigated. The resulting nanospheres demonstrated substantial contrast enhancement during the in vitro MRI investigations, which was also evidenced by significant contrast enhancement on T1-weighted MR images in vivo. Moreover, in vitro cytotoxicity assay of functionalized MSNSs on hepatocyte mono- and hepatocyte-Kuppfer cell co-cultures showed no significant decrease in cell viability. Our findings confirmed our hypothesis, that Mn2+-chelating MSNSs are appropriate candidates for liver-specific T1-weighted MRI CAs with high relaxivities (r1=7.18mM-1s-1).
Journal of Bioactive and Compatible Polymers | 1990
Mária Azori; Zsuzsanna Veres; Géza Dénes; F. Tüdös
Acute toxicity of the copolymer of poly(N-vinylpyrrolidone-alt-maleic acid) is examined by two routes of parenteral administration. The effect of prolonged daily treatment of animals, the results of hemagglutination tests of the original, and the modified copolymer as polymer drug models are discussed.
Scientific Reports | 2017
Tibor Kovács; Domokos Máthé; András Fülöp; Katalin Jemnitz; Attila Bátai-Konczos; Zsuzsanna Veres; György Török; Dániel S. Veres; Ildiko Horvath; Krisztián Szigeti; László Homolya; Attila Szijártó
Selective portal vein ligation (PVL) allows the two-stage surgical resection of primarily unresectable liver tumours by generating the atrophy and hypertrophy of portally ligated (LL) and non-ligated lobes (NLL), respectively. To evaluate critically important underlying functional alterations, present study characterised in vitro and vivo liver function in male Wistar rats (n = 106; 210–250 g) before, and 24/48/72/168/336 h after PVL. Lobe weights and volumes by magnetic resonance imaging confirmed the atrophy-hypertrophy complex. Proper expression and localization of key liver transporters (Ntcp, Bsep) and tight junction protein ZO-1 in isolated hepatocytes demonstrated constantly present viable and well-polarised cells in both lobes. In vitro taurocholate and bilirubin transport, as well as in vivo immunohistochemical Ntcp and Mrp2 expressions were bilaterally temporarily diminished, whereas LL and NLL structural acinar changes were divergent. In vivo bile and bilirubin-glucuronide excretion mirrored macroscopic changes, whereas serum bilirubin levels remained unaffected. In vivo functional imaging (indocyanine-green clearance test; 99mTc-mebrofenin hepatobiliary scintigraphy; confocal laser endomicroscopy) indicated transitionally reduced global liver uptake and -excretion. While LL functional involution was permanent, NLL uptake and excretory functions recovered excessively. Following PVL, functioning cells remain even in LL. Despite extensive bilateral morpho-functional changes, NLL functional increment restores temporary declined transport functions, emphasising liver functional assessment.
Drugs Under Experimental and Clinical Research | 1987
Zsuzsanna Veres; Istvan Szinai; Anna Szabolcs; K. Ujszaszy; Géza Dénes
Macromolecular Chemistry and Physics | 1986
Mária Azori; Istvan Szinai; Zsuzsanna Veres; János Pató; L. Ötvös; Ferenc Tüdős
Archive | 2013
Gábor Mátis; György Csikó; Katalin Jemnitz; Zsuzsanna Veres; Hedvig Fébel; Anna Kulcsár; Janka Petrilla; Zsuzsanna Neogrády
Archive | 2013
Gábor Mátis; Zsuzsanna Neogrády; György Csikó; Péter Gálfi; Hedvig Fébel; Katalin Jemnitz; Zsuzsanna Veres; Anna Kulcsár; Ákos Kenéz; Korinna Huber
Archive | 2007
Zsuzsanna Veres; Márta Csík; Katalin Jemnitz; György Lengyel; Géza Török
Acta pharmaceutica Hungarica | 1998
L. Vereczkey; Katalin Monostory; Zsuzsanna Veres